<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Allogeneic stem cell transplantation (allo-SCT) is used as curative therapy for malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and reduced-intensity hematopoietic stem cell transplantation (RIST) is sometimes performed to avoid the toxicity and mortality associated with myeloablative allo-SCT </plain></SENT>
<SENT sid="1" pm="."><plain>RIST is generally preferred for elderly patients with malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A 62-year-old woman with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) involving bone marrow (BM) suffered relapse after autologous SCT </plain></SENT>
<SENT sid="3" pm="."><plain>RIST was performed; cells were from an unrelated, fully human leukocyte antigen-matched donor </plain></SENT>
<SENT sid="4" pm="."><plain>To study the hematopoietic reconstitution, BM biopsy specimens that were obtained at different times after RIST, were evaluated </plain></SENT>
<SENT sid="5" pm="."><plain>Engraftment of donor cells was observed on days 19 and 48 after RIST, and residual FL in BM had completely disappeared by day 73 after RIST </plain></SENT>
<SENT sid="6" pm="."><plain>This is the first report to document histological BM regeneration after RIST and disappearance of FL involving the BM </plain></SENT>
</text></document>